Researcher Profile

Miss Abbie Adams

Abbie Adams
Abbie Adams
  1. 2016
  2. 1

    Deletion of dystrophin in-frame exon 5 leads to a severe phenotype: Guidance for exon skipping strategies

    Toh, Z. Y. C., Aung-Htut, M. T., Pinniger, G., Adams, A., Krishnaswarmy, S., Wong, B. L., Fletcher, S. & Wilton, S. 8 Jan 2016 In : PLoS ONE. 11, 1, p. 1-17 e0145620

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  3. 2014
  4. Antisense oligonucleotide induction of progerin in human myogenic cells

    Luo, Y., Mitrpant, C., Adams, A., Johnsen, R., Fletcher, S., Mastaglia, F. & Wilton, S. 2014 In : PLoS One. 9, 6, p. 9pp

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  5. 2012
  6. Multiple exon skipping strategies to by-pass dystrophin mutations

    Adkin, C., Meloni, P., Fletcher, S., Adams, A., Muntoni, F., Wong, B. & Wilton, S. 2012 In : Neuromuscular Disorders. 22, 4, p. 297-305

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  7. 2011
  8. Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching

    Fragall, C., Adams, A., Johnsen, R., Kole, R., Fletcher, S. & Wilton, S. 2011 In : BMC Medical Genetics. 12, p. 141

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  9. 2010
  10. Dystrophin isoform induction in vivo by antisense-mediated alternative splicing

    Fletcher, S., Adams, A., Johnsen, R., Greer, K., Moutlon, H. M. & Wilton, S. 2010 In : Molecular Therapy. 18, 6, p. 1218-1223

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  11. 2009
  12. Rational design of antisense oligomers to induce dystrophin exon skipping

    Mitrpant, C., Adams, A., Meloni, P., Muntoni, F., Fletcher, S. & Wilton, S. 2009 In : Molecular Therapy. 17, 8, p. 1418-1426

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  13. 2008
  14. Antisense oligomer design: Targeting and assay systems

    Wilton, S., Mitrpant, C., Meloni, P., Adams, A. & Fletcher, S. 2008 NEUROMUSCULAR DISORDERS. Vol. 18, p. 756-756

    Research output: Chapter in Book/Report/Conference proceedingConference publication

  15. 2007
  16. Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries

    Adams, A., Meloni, P., Iversen, P. L., Coleman, C., Fletcher, S. & Wilton, S. 2007 In : BMC Molecular Biology. 8, p. 1-8

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  17. Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript

    Wilton, S., Adams, A., Meloni, P., Mcclorey, G., Coleman, C. & Fletcher, S. 2007 In : Molecular Therapy. 15, 7, p. 1288-1296

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  18. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle

    Arechavala-Gomeza, V., Graham, I. R., Popplewell, L. J., Adams, A., Aartsma-Rus, A., Kinali, M., Morgan, J. E., Van Deutekom, J. C., Wilton, S., Dickson, G. & Muntoni, F. 2007 In : Human Gene Therapy. 18, 9, p. 798-810

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  19. Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse

    Fletcher, S., Wright, K., Adams, A., Meloni, P., Johnsen, R., Steinhaus, J. P., Moulton, H. M., Iversen, P. L. & Wilton, S. 2007 In : Molecular Therapy. 15, 9, p. 1587-1592

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  20. The influence of antisense oligonucleotide length on dystrophin exon skipping

    Harding, P., Fall, A., Honeyman, K., Fletcher, S. & Wilton, S. 2007 In : Molecular Therapy. 15, 1, p. 157-166

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  21. 2006
  22. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide

    Fletcher, S., Honeyman, K., Fall, A., Harding, P., Johnsen, R. & Wilton, S. 2006 In : The Journal of Gene Medicine. 8, 2, p. 207-216

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  23. Induced dystrophin exon skipping in human muscle explants

    Mcclorey, G., Fall, A., Moulton, H. M., Iversen, P. L., Rasko, J. E., Ryan, M., Fletcher, S. & Wilton, S. 2006 In : Neuromuscular Disorders. 16, 9-10, p. 583-590

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  24. 2004
  25. EphA/ephrin-A interactions during optic nerve regeneration: restoration of topography and regulation of ephrin-A2 expression

    Rodger, J., Vitale, P. N., Tee, L., King, C. E., Bartlett, C., Fall, A., Brennan, C., O'Shea, J., Dunlop, S. & Beazley, L. 2004 In : Molecular and Cellular Neuroscience. 25, 1, p. 56-68

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  26. 2003
  27. A possible role for the axon guidance molecule ephrin-A2 in activity-dependent refinement of regenerating central nerve connections

    King, C., Fall, A., Quach, T., Bartlett, C., Rodger, J., Dunlop, S. & Beazley, L. 2003 22nd Symposium of Western Australian Neuroscience. Fall, A., Madja, B. & Byrnes, M. (eds.). Nedlands, WA ed. Australia: Symposium of Western Australian Neuroscience, Vol. 1, p. 30

    Research output: Chapter in Book/Report/Conference proceedingConference publication

  28. A possible role for the axon guidance molecule eprhin-A2 in activity-dependent refinement of regenerating central nerve connections

    Quach, T., Fall, A., King, C., Bartlett, C., Rodger, J., Dunlop, S. & Beazley, L. 2003 Fourteenth Annual Combined Biological Sciences Meeting. Newberry, J. A., Quail, E. A. & Watson, M. (eds.). Scarborough, WA ed. Australia: BioMed Chem, Vol. 1, p. 38

    Research output: Chapter in Book/Report/Conference proceedingConference publication

  29. The Axon Repulsive Molecule Ephrin-A2 Is Up-Regulated After Insertion Of A Peripheral Nerve Into The Rate Superior Colliculus

    Symonds, A., Sauce, Y., Rodger, J., King, C., Bartlett, C., Fall, A., Dunlop, S., Lund, R. & Beazley, L. 2003 Fourteenth Annual Combined Biological Science Meeting. Newberry, J. A., Quail, E. A. & Watson, M. (eds.). Scarborough, WA ed. Australia: BioMed Chem, Vol. 1, p. 43

    Research output: Chapter in Book/Report/Conference proceedingConference publication

  30. Up-regulation of the axon guidance molecule ephrin-A2 after insertion of a peripheral nerve into the rat superior colliculus

    Symonds, A., Sauve, Y., Rodger, J., King, C., Bartlett, C., Fall, A., Dunlop, S., Lund, R. & Beazley, L. 2003 22nd Symposium of Western Australian Neuroscience. Nedlands, WA ed. Australia: Symposium of Western Australian Neuroscience, Vol. 1, p. 27

    Research output: Chapter in Book/Report/Conference proceedingConference publication

ID: 85657

Highlighted content
  1. 1

    Deletion of dystrophin in-frame exon 5 leads to a severe phenotype: Guidance for exon skipping strategies

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  2. Antisense oligonucleotide induction of progerin in human myogenic cells

    Research output: Contribution to journalRefereed article in scholarly journal (C1)

  3. View all (20) »

Most frequent journals
  • Molecular Therapy

    ISSNs: 1525-0016

    Nature Publishing Group

    Scopus rating (2015): SJR 3.374 SNIP 1.339

    Journal

  • Neuromuscular Disorders

    ISSNs: 0960-8966

    Elsevier Limited

    Scopus rating (2015): SJR 1.447 SNIP 1.159

    Journal

  • PLoS One

    ISSNs: 1932-6203

    Public Library of Science

    Scopus rating (2015): SJR 1.395 SNIP 1.044

    Journal

  • Journal of Gene Medicine

    ISSNs: 1099-498X

    John Wiley and Sons Ltd

    Scopus rating (2015): SJR 1.025 SNIP 0.742

    Journal

  • BMC Medical Genetics

    ISSNs: 1471-2350

    BioMed Central

    Scopus rating (2015): SJR 1.062 SNIP 0.798

    Journal

View all »

Most frequent publishers